Morgan Stanley’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.1M Buy
524,480
+20,431
+4% +$1.29M ﹤0.01% 2303
2025
Q1
$26.7M Sell
504,049
-56,038
-10% -$2.97M ﹤0.01% 2397
2024
Q4
$31.4M Buy
560,087
+95,483
+21% +$5.35M ﹤0.01% 2292
2024
Q3
$24.3M Sell
464,604
-11,047
-2% -$579K ﹤0.01% 2599
2024
Q2
$19.5M Buy
475,651
+292,781
+160% +$12M ﹤0.01% 2698
2024
Q1
$7.92M Sell
182,870
-280,442
-61% -$12.2M ﹤0.01% 3525
2023
Q4
$21.3M Buy
463,312
+26,904
+6% +$1.24M ﹤0.01% 3278
2023
Q3
$10M Buy
436,408
+333,227
+323% +$7.64M ﹤0.01% 3126
2023
Q2
$1.7M Sell
103,181
-113,440
-52% -$1.87M ﹤0.01% 4519
2023
Q1
$3.86M Sell
216,621
-27,064
-11% -$483K ﹤0.01% 3985
2022
Q4
$7.1M Buy
243,685
+13,488
+6% +$393K ﹤0.01% 3420
2022
Q3
$5.64M Sell
230,197
-200,550
-47% -$4.91M ﹤0.01% 3577
2022
Q2
$1.79M Buy
430,747
+175,255
+69% +$727K ﹤0.01% 4618
2022
Q1
$2.94M Sell
255,492
-12,871
-5% -$148K ﹤0.01% 4213
2021
Q4
$2.68M Buy
268,363
+62,897
+31% +$628K ﹤0.01% 4339
2021
Q3
$2.68M Sell
205,466
-241,140
-54% -$3.15M ﹤0.01% 4327
2021
Q2
$8.74M Buy
446,606
+345,757
+343% +$6.77M ﹤0.01% 3141
2021
Q1
$2.15M Buy
100,849
+50,643
+101% +$1.08M ﹤0.01% 4201
2020
Q4
$1.49M Buy
50,206
+34,527
+220% +$1.03M ﹤0.01% 4400
2020
Q3
$340K Sell
15,679
-8,872
-36% -$192K ﹤0.01% 4842
2020
Q2
$548K Buy
24,551
+13,451
+121% +$300K ﹤0.01% 4551
2020
Q1
$169K Sell
11,100
-47,774
-81% -$727K ﹤0.01% 4939
2019
Q4
$1.35M Buy
58,874
+46,135
+362% +$1.06M ﹤0.01% 4319
2019
Q3
$274K Buy
12,739
+10,888
+588% +$234K ﹤0.01% 4975
2019
Q2
$40K Sell
1,851
-2,758
-60% -$59.6K ﹤0.01% 5701
2019
Q1
$127K Sell
4,609
-21,005
-82% -$579K ﹤0.01% 5284
2018
Q4
$689K Sell
25,614
-1,038
-4% -$27.9K ﹤0.01% 4581
2018
Q3
$777K Sell
26,652
-2,994
-10% -$87.3K ﹤0.01% 4714
2018
Q2
$927K Buy
29,646
+12,866
+77% +$402K ﹤0.01% 4678
2018
Q1
$334K Sell
16,780
-9,867
-37% -$196K ﹤0.01% 5226
2017
Q4
$775K Buy
+26,647
New +$775K ﹤0.01% 4718